Silver Grove Financial Group »

Lexeo Therapeutics shares owned by Silver Grove Financial Group

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Silver Grove Financial Group from 13F filings

Historical chart of Silver Grove Financial Group investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Silver Grove Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Silver Grove Financial Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $47 10 4.70

More positions owned by Silver Grove Financial Group

Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Advisors Inner Circle Fd Ii 3edge Fixed Etf (EDGF)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Ishares Tr National Mun Etf (MUB)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Silver Grove Financial Group

Top funds holding Lexeo Therapeutics

Suvretta Capital Management
Affinity Asset Advisors
BlackRock
RA Capital Management
Henderson Group
Frazier Life Sciences Management
Vestal Point Capital
Paradigm Biocapital Advisors
Jupiter Topco
OrbiMed Advisors
Citadel Advisors
State Street Corporation
Vanguard Capital Management
Millennium Management
Woodline Partners

View all funds holding Lexeo Therapeutics